PharmaResearch Forms New Alliance for Rejuran Across Europe

PharmaResearch Teams Up with VIVACY for European Expansion

PharmaResearch is excited to announce a strategic partnership with VIVACY, a leading player in the medical aesthetics industry, to distribute its innovative medical device brand, Rejuran, throughout Europe. This collaboration is set to significantly enhance their distribution reach across 22 countries, enabling them to tap into vital markets, including the UK, Germany, and France.

About the Strategic Partnership

VIVACY, known for its established distribution network and marketing prowess, will play a crucial role in this partnership. With offices in key European cities, VIVACY brings a wealth of experience to the table. The two companies aim to leverage their combined strengths to ensure a successful rollout of Rejuran, which is already gaining recognition for its effectiveness as a skin booster in the medical aesthetics space.

The Scope of the Agreement

This distribution agreement holds a remarkable value and spans five years, focusing on major markets in Western Europe including the UK, Germany, France, Italy, and Spain. PharmaResearch is optimistic about beginning operations within these key areas soon and plans to implement a phased approach for distribution across the region.

CEO Insights

Jihoon Sohn, the CEO of PharmaResearch, expressed confidence in their product. He stated that "Rejuran is the only PN (Polynucleotide)-based medical device approved under the EU Medical Device Regulation (MDR). This strategic alliance is crucial for enhancing Rejuran's visibility and solidifying its status as a leading skin care solution in the international market." His vision is to make Rejuran synonymous with high-quality skin rejuvenation.

VIVACY's Perspective

Bertrand, CEO of VIVACY, also shared exciting insights regarding the partnership. He believes that the combination of Rejuran's premium positioning, superior product quality, and proven efficacy aligns perfectly with VIVACY’s reputation for excellence in science and commercial reach. He emphasized that this partnership will provide physicians with state-of-the-art Polynucleotide technology, further advancing patient care in skin regeneration.

About PharmaResearch

PharmaResearch is dedicated to enhancing quality of life through advances in regenerative medicine. This biopharmaceutical company boasts a diverse range of products, including medicines, medical devices, cosmetics, and dietary supplements. They emphasize utilizing core ingredients like DOT™ PDRN and DOT™ PN while holding several patents protecting their innovations. Their headquarters are located in Gangneung-si, Gangwon-do, South Korea, along with a subsidiary in Costa Mesa, California.

About Laboratoires VIVACY

Founded in 2007 and headquartered in Paris, Laboratoires VIVACY specializes in premium hyaluronic acid-based medical devices, well-known for their advanced technologies. Their flagship products include STYLAGE® dermal fillers and innovative treatments like DESIRIAL®, the first injectable designed for both aesthetic and functional gynecology. VIVACY has recently partnered on the NOVUMA® biostimulator, exemplifying their commitment to pioneering advancements in regenerative aesthetics.

Frequently Asked Questions

1. What is the main focus of the partnership between PharmaResearch and VIVACY?

The partnership focuses on distributing Rejuran in 22 European countries, aiming to enhance its presence in key markets.

2. How long is the distribution agreement set to last?

The distribution agreement is set for a duration of five years.

3. What regions will be primarily targeted for Rejuran distribution?

The primary markets include the UK, Germany, France, Italy, and Spain.

4. Who is the CEO of PharmaResearch?

The CEO of PharmaResearch is Jihoon Sohn.

5. What is unique about Rejuran in the EU market?

Rejuran is the only medical device based on Polynucleotides that is approved under the EU Medical Device Regulation (MDR).

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.